CardioKinetix heads to Malaysia to treat the 1st Asian patients with the Parachute ventricular partitioning device.
Four patients in Kuala Lumpur, Malaysia were successfully treated with CardioKinetix’s catheter-based Parachute ventricular partitioning device, the Menlo Park, Calif.-based firm announced late last month.
The Parachute device is a minimally invasive catheter-based treatment which separates damaged heart muscle from healthy tissue to decrease the overall volume of the left ventricle and restore its geometry and function.
![An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2025/04/Edwards-Lifesciences-Sapien-M3-TMVR-valve-delivery-268x170.jpg)